Immunology and Microbiology
Cathelicidin
100%
Host Resistance
74%
Mouse
69%
Cells
62%
Neutrophil Granulocyte
57%
Electric Potential
51%
Antiviral Activity
41%
Inflammation
41%
Human Respiratory Syncytial Virus
34%
Antimicrobial Peptides
29%
Macrophage
28%
TLR9
27%
Pseudomonas aeruginosa
25%
Defensin
21%
Skin
21%
Viral Disease
20%
Respiratory Syncytial Virus Infection
20%
Microflora
19%
Dendritic Cell
19%
Birth
18%
Comprehension
16%
Innate Immune System
16%
Infectious Agent
16%
Development
16%
Normal Human
16%
Mediator
15%
Interferon Type I
15%
Atopic Dermatitis
15%
Human
14%
Phenotype
14%
Keratinocyte
14%
Differentiation
14%
Host
14%
Bacterium
13%
Clearance
13%
Staphylococcus Aureus
13%
Lung
13%
Age
13%
Morbidity
12%
Density
12%
Labor Onset
12%
Prostaglandin
12%
MDA5
12%
Inflammatory Cell
12%
Health
12%
Systemic Inflammation
12%
Immunotherapy
12%
TLR3
12%
Interleukin 1beta
12%
Polyinosinic:polycytidylic Acid
12%
DNA RNA Hybridization
12%
Leukotriene
12%
Permeability
12%
Placental Mammal
12%
Respiratory Syncytial Virus
12%
NOD2
12%
Influenza
12%
Wound Healing Impairment
12%
Labor
11%
Phagocytosis
11%
Virus
11%
Immune Response
9%
Staphylococcus aureus
8%
Mortality
8%
Liquid
8%
Pregnancy
7%
Proinflammatory Cytokine
7%
Tumor Necrosis Factor Alpha
6%
Bactericidal Activity
6%
Influenza Virus
6%
Germfree Mouse
5%
Vaccine Efficacy
5%
Degranulation
5%
Apoptosis
5%
Medicine and Dentistry
Cathelicidin
63%
Infection
52%
Neutrophil
49%
Serositis
32%
Human Respiratory Syncytial Virus
32%
Host Resistance
26%
Antiviral Activity
25%
Cystic Fibrosis
24%
Bronchiectasis
24%
Extracellular Trap
24%
Blood
22%
Epithelial Cell
21%
Patient
21%
Respiratory Syncytial Virus Infection
20%
Antiinfective Agent
19%
Peptide
18%
Programmed Cell Death
18%
Therapeutic Procedure
18%
Pneumonia
15%
Human
15%
In Vitro
15%
Cells
14%
Bacterium
13%
Cathelicidin Antimicrobial Peptide LL 37
13%
Phenotype
13%
Prematurity
13%
Interferon Type I
13%
Virus Infection
13%
Premature Labor
13%
Pseudomonas aeruginosa
13%
Lipopolysaccharide
12%
Cervix
12%
Labor Onset
12%
Peptides and Proteins
12%
Peripheral Blood Mononuclear Cell
12%
Atorvastatin
12%
Polyinosinic Polycytidylic Acid
12%
Toll Like Receptor 3
12%
Human Milk
12%
Neonatal Sepsis
12%
Placebo
12%
Wound Healing Impairment
12%
Randomized Controlled Trial
12%
Depletion
12%
Gut
12%
NLR Family Pyrin Domain containing 3
12%
Protein Kinase C
12%
Lung
12%
Inpatient
12%
Volunteer
11%
Secretion (Process)
10%
Monocyte
9%
Pregnancy
9%
Pathogen
9%
Woman
8%
Infant
7%
Cytokine
7%
Lung Lavage
7%
Protein
7%
Phagocytosis
7%
Antivirus Agent
7%
Epithelial Cell Line
6%
Coughing
6%
Calcifediol
6%
Morbidity
5%
Regulatory Mechanism
5%
Respiratory Syncytial Virus
5%
Mortality
5%
Immune Response
5%
Virus
5%
Biochemistry, Genetics and Molecular Biology
Cathelicidin
38%
Mouse
34%
Defensin
33%
Peptide
30%
Host Resistance
28%
TLR9
24%
DNA
24%
Beta-Defensin 2
24%
Electric Potential
21%
Birth
18%
Keratinocyte
14%
Human Respiratory Syncytial Virus
14%
Host
14%
Antiviral Activity
14%
Protease
13%
Staphylococcus Aureus
13%
Infectious Agent
13%
Cystic Fibrosis
12%
NOD2
12%
Atorvastatin
12%
Pseudomonas aeruginosa
12%
Labor Onset
12%
Density
12%
DNA RNA Hybridization
12%
TLR3
12%
Health
12%
Phenotype
12%
Protein Kinase C
12%
Macrophage
12%
MDA5
12%
Wound Healing Impairment
12%
Innate Immunity
12%
Labor
11%
Virus
9%
Immune Response
7%
Development
7%
Dendritic Cell
7%
Interleukin-6
6%
Pregnancy
5%
Morbidity
5%
Protein
5%
Comprehension
5%